Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial (vol 22, pg 29, 2021)

被引：0
|
作者：
Bahadoer, R. R.
Dijkstra, E. A.
van Etten, B.
机构：
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 43 条
  • [21] PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).
    Schrag, Deborah
    Shi, Qian
    Weiser, Martin R.
    Gollub, Marc J.
    Saltz, Leonard B.
    Musher, Benjamin Leon
    Goldberg, Joel
    Al Baghdadi, Tareq
    Goodman, Karyn A.
    McWilliams, Robert R.
    Farma, Jeffrey M.
    George, Thomas J.
    Kennecke, Hagen Fritz
    Venook, Alan P.
    O'Reilly, Eileen Mary
    Meyerhardt, Jeffrey A.
    Dueck, Amylou C.
    Basch, Ethan
    Chang, George J.
    Mamon, Harvey J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [22] A phase II open-label prospective study of preoperative chemoradiation with oxaliplatin/5FU in locally advanced rectal cancer followed by total mesorectal excision and adjuvant FOLFOX6.
    Siu, K.
    Young, R.
    Kozuch, P.
    Mirzoyev, T.
    Rosenwald, V.
    Francois, D.
    Cohen, S. M.
    Hu, K.
    Grossbard, M. L.
    Malamud, S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial (vol 147, pg 75, 2020)
    van der Valk, Maxime J. M.
    Marijnen, Corrie A. M.
    van Etten, Boudewijn
    Dijkstra, Esmee A.
    Hilling, Denise E.
    Kranenbarg, Elma Meershoek-Klein
    Putter, Hein
    Roodvoets, Annet G. H.
    Bahadoer, Renu R.
    Fokstuen, Tone
    ten Tije, Albert Jan
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres M. R.
    de Groot, Derk Jan A.
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 147 : E1 - E1
  • [24] Randomized phase II trial comparing two strategies in high-risk rectal cancer (RC): Chemoradiation (CRT) followed by total mesorectal excision (TME) and adjuvant chemotherapy (CT) or induction CT followed by CRT and TME-Preliminary results of the multicenter GCR-3 study
    Fernandez-Martos, C.
    Pericay, C.
    Salud, A.
    Alonso, V.
    Massuti, B.
    Safont, M.
    Vera, R.
    Escudero, P.
    Maurel, J.
    Aparicio, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial
    Ding, P-R.
    Wang, X-Z.
    Li, Y-F.
    Sun, Y-M.
    Yang, C-K.
    Wu, Z-G.
    Zhang, R.
    Wang, W.
    Li, Y.
    Zhuang, Y-Z.
    Lei, J.
    Wan, X-B.
    Ren, Y-K.
    Cheng, Y.
    Li, W-L.
    Wang, Z-Q.
    Pan, Z-Z.
    Gao, Y-H.
    Zeng, Z-F.
    Wan, D-S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1296 - S1296
  • [26] Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial
    Bourhis, Jean
    Sire, Christian
    Graff, Pierre
    Gregoire, Vincent
    Maingon, Philippe
    Calais, Gilles
    Gery, Bernard
    Martin, Laurent
    Alfonsi, Marc
    Desprez, Patrick
    Pignon, Thierry
    Bardet, Etienne
    Rives, Michel
    Geoffrois, Lionel
    Daly-Schveitzer, Nicolas
    Sen, Sok
    Tuchais, Claude
    Dupuis, Olivier
    Guerif, Stephane
    Lapeyre, Michel
    Favrel, Veronique
    Hamoir, Marc
    Lusinchi, Antoine
    Temam, Stephane
    Pinna, Antonella
    Tao, Yun Gan
    Blanchard, Pierre
    Auperin, Anne
    LANCET ONCOLOGY, 2012, 13 (02): : 145 - 153
  • [27] Preoperative Short-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor Administration for Locally Advanced Rectal Cancer: The Initial Results of a Randomized Phase II/III Trial (STELLAR II study)
    Tang, Y.
    Zhou, H.
    Hu, C.
    Wei, L.
    Zhang, Y.
    Zhang, W.
    Feng, L.
    Li, N.
    Meng, X.
    Lu, Y.
    Song, Y.
    Qi, S.
    Jing, H.
    Zhai, Y.
    Li, Y.
    Jin, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E462 - E462
  • [28] Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trial
    Zhang, Zi-Tong
    Xiao, Wei-Wei
    Li, Li-Ren
    Wu, Xiao-Jun
    Wang, Qiao-Xuan
    Chang, Hui
    Tian, Xue
    Jiang, Wu
    Lin, Jun-Zhong
    Zhang, Rong-Xin
    Fan, Wen-Hua
    Pan, Zhi-Zhong
    Zhang, Rong
    Gao, Yuan-Hong
    ECLINICALMEDICINE, 2024, 76
  • [29] Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study)
    Zhang, Wenjue
    Tang, Yuan
    Wei, Lichun
    Liu, Shixin
    Wang, Wenling
    Chi, Yihebali
    Wang, Ying
    Kang, Wenyan
    Huang, Wenting
    Deng, Feiyan
    Li, Haoyue
    Ma, Huiying
    Jiang, Liming
    Ding, Zhen
    Feng, Lingling
    Li, Yexiong
    Chen, Yinggang
    Zhou, Haitao
    Hu, Chen
    Jin, Jing
    COLORECTAL DISEASE, 2024, 26 (09) : 1732 - 1740
  • [30] Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial
    Fokas, E.
    Allgaeuer, M.
    Polat, B.
    Klautke, G.
    Grabenbauer, G.
    Fietkau, R.
    Kuhnt, T.
    Staib, L.
    Brunner, T.
    Grosu, A-L
    Schmiegel, W.
    Jacobasch, L.
    Weitz, J.
    Folprecht, G.
    Schleska-Lange, A.
    Flentje, M.
    Gruetzmann, R.
    Schwarzbach, M.
    Paolucci, V
    Bechstein, W. -O
    Friede, T.
    Ghadimi, M.
    Hofheinz, R. -D
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S40 - S40
12345